SCHEMBL8565151

SCHEMBL8565151

CC(C)(C)Cc1c(Cl)ccc2[nH][c]nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18894158 0.82 SIRT1 (0.31) —
SCHEMBL18894139 0.79 NOTUM (0.33) —
SCHEMBL8563838 0.76 SIRT1 (0.30) —
SCHEMBL8558658 0.74 CCNB2 (0.37) —
SCHEMBL10832750 0.72 MEN1 (0.30) —
SCHEMBL8564117 0.71 CCNB2 (0.41) —
SCHEMBL6032862 0.66 PDE3B (0.30) —
SCHEMBL10026846 0.66 ESR1 (0.33) —
SCHEMBL1886180 0.65 PSMB8 (0.41) —
SCHEMBL6980883 0.63 TAAR1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821675-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-02-04 — — EP disclosed
WO-1996033176-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-10-24 — — WO disclosed
Send feedback